Question 1

What is AbbVie's P/S ratio?

Accepted Answer

AbbVie (ABBV) P/S ratio is 6.4× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for AbbVie?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For AbbVie specifically, the relevant sector benchmark is the current sector median of 3.5×.

Question 5

Is AbbVie's P/S ratio high or low?

Accepted Answer

AbbVie's P/S ratio of 6.4× is above its own 5-year average of 5.2× and above the sector median of 3.5×. That places the current reading at the 87th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is AbbVie's historical P/S ratio range?

Accepted Answer

In the available daily series, AbbVie (ABBV) P/S ratio has ranged from a low of 2.9× in 2012 to a high of 7.4× in 2025. The 5-year average is 5.2× and the 5-year median is 5.0×.

Question 7

What was AbbVie's P/S ratio in 2025?

Accepted Answer

AbbVie (ABBV) P/S ratio at the end of 2025 was 6.7×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does AbbVie's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$406.80B	$61.16B	6.7×	+1.1×	Dec 31, 2025
2024	$314.35B	$56.33B	5.6×	+0.5×	Dec 31, 2024
2023	$273.67B	$54.32B	5.0×	+0.1×	Dec 31, 2023
2022	$285.92B	$58.05B	4.9×	+0.7×	Dec 31, 2022
2021	$239.43B	$56.20B	4.3×	+0.1×	Dec 31, 2021
2020	$189.55B	$45.80B	4.1×	+0.2×	Dec 31, 2020
2019	$130.94B	$33.27B	3.9×	-0.2×	Dec 31, 2019
2018	$136.56B	$32.75B	4.2×	-1.3×	Dec 31, 2018
2017	$153.97B	$28.22B	5.5×	+1.6×	Dec 31, 2017
2016	$99.72B	$25.64B	3.9×	-0.3×	Dec 31, 2016
2015	$95.37B	$22.86B	4.2×	-1.0×	Dec 31, 2015
2014	$104.14B	$19.96B	5.2×	+0.8×	Dec 31, 2014
2013	$83.83B	$18.79B	4.5×	+1.5×	Dec 31, 2013
2012	$54.10B	$18.38B	2.9×	-0.2×	Dec 31, 2012
2011	$55.30B	$17.44B	3.2×	—	Dec 31, 2011


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for AbbVie (ABBV)

P/S Ratio daily chart for AbbVie (ABBV)

Historical P/S Ratio for AbbVie (ABBV) from 2011 to 2025

About P/S Ratio at AbbVie (ABBV)

AbbVie P/S Ratio by Year

AbbVie P/S Ratio 2025: 6.7×

AbbVie P/S Ratio 2024: 5.6×

AbbVie P/S Ratio 2023: 5.0×

AbbVie P/S Ratio 2022: 4.9×

AbbVie P/S Ratio 2021: 4.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

AbbVie (ABBV) Key Financials

P/S Ratio daily chart for AbbVie (ABBV)

Historical P/S Ratio for AbbVie (ABBV) from 2011 to 2025

About P/S Ratio at AbbVie (ABBV)

AbbVie P/S Ratio by Year

AbbVie P/S Ratio 2025: 6.7×

AbbVie P/S Ratio 2024: 5.6×

AbbVie P/S Ratio 2023: 5.0×

AbbVie P/S Ratio 2022: 4.9×

AbbVie P/S Ratio 2021: 4.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is AbbVie's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for AbbVie?

+Is AbbVie's P/S ratio high or low?

+What is AbbVie's historical P/S ratio range?

+What was AbbVie's P/S ratio in 2025?

+Why does AbbVie's P/S ratio change over time?

AbbVie (ABBV) Key Financials